Neumora Therapeutics (NMRA) Insider Trading & Ownership $9.74 +0.05 (+0.52%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Neumora Therapeutics (NASDAQ:NMRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.39 M Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NMRA Insider Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Neumora Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/18/2024Matthew K FustDirectorSell14,049$17.03$239,254.47 10/9/2024Robert A LenzInsiderSell5,563$15.01$83,500.63 9/17/2024Robert A LenzInsiderSell30,788$11.81$363,606.28 8/26/2024Joshua PintoCFOSell31,642$11.78$372,742.76 8/22/2024Joshua PintoCFOSell28,496$11.63$331,408.48 (Data available from 1/1/2013 forward) NMRA Insider Trading Activity - Frequently Asked Questions Who is on Neumora Therapeutics's Insider Roster? The list of insiders at Neumora Therapeutics includes Amgen Inc, Arch Venture Partners Xii, Llc, Henry O Gosebruch, Joshua Pinto, Kristina Burow, Matthew K Fust, and Robert A Lenz. Learn more on insiders at NMRA. What percentage of Neumora Therapeutics stock is owned by insiders? 26.40% of Neumora Therapeutics stock is owned by insiders. Learn more on NMRA's insider holdings. Which Neumora Therapeutics insiders have been buying company stock? The following insiders have purchased NMRA shares in the last 24 months: Amgen Inc ($29,999,985.00), Arch Venture Partners Xii, Llc ($2,626,582.57), Henry O Gosebruch ($189,300.00), and Kristina Burow ($28,803,319.17). How much insider buying is happening at Neumora Therapeutics? Insiders have purchased a total of 3,786,769 NMRA shares in the last 24 months for a total of $61,619,186.74 bought. Which Neumora Therapeutics insiders have been selling company stock? The following insiders have sold NMRA shares in the last 24 months: Joshua Pinto ($704,151.24), Matthew K Fust ($239,254.47), and Robert A Lenz ($447,106.91). How much insider selling is happening at Neumora Therapeutics? Insiders have sold a total of 110,538 Neumora Therapeutics shares in the last 24 months for a total of $1,390,512.62 sold. Neumora Therapeutics Key ExecutivesMr. Paul L. Berns (Age 57)Co-Founder & Executive Chairman Compensation: $1.65MMr. Henry O. Gosebruch (Age 51)President, CEO & Director Compensation: $3.33MMr. Jason G. Duncan (Age 50)Chief Legal Officer Compensation: $315kMr. Robert Lenz M.D. (Age 53)Ph.D., Head of Research & Development Compensation: $770.29kMs. Carol Suh (Age 34)Co-Founder & COO Dr. Robert Michael Poole FACP (Age 67)M.D., Co-Founder & Advisor Dr. Joshua Pinto Ph.D. (Age 39)Chief Financial Officer Compensation: $876.64kMr. Michael Lee MilliganPrincipal Accounting OfficerDr. Rajesh Manchanda Ph.D. (Age 58)Chief Technical Operations Officer Mr. Nicholas Brandon Ph.D. (Age 50)Chief Scientific Officer More Insider Trading Tools from MarketBeat Related Companies Halozyme Therapeutics Insider Trading Krystal Biotech Insider Trading ADMA Biologics Insider Trading Arcellx Insider Trading CRISPR Therapeutics Insider Trading Immunovant Insider Trading ImmunityBio Insider Trading Denali Therapeutics Insider Trading Kymera Therapeutics Insider Trading Vericel Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:NMRA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
